Interaction of Quinolones with Metal Cations in Aqueous Solution
スポンサーリンク
概要
- 論文の詳細を見る
Quinolones are a group of potent antibacterial agents. Many reports show that oral absorption of quinolones is reduced by coadministration of metallic preparations. For better understanding of this phenomenon, we investigated the complex formations of quinolones (DU-6859a, DV-7751a, DR-3862,levofloxacin) with various metal cations by pH titrations, NMR and spectrophotometry. Several metal complexes including hydroxo species were confirmed by pH titrations. The order of stability constants among trivalent metal cations was Fe^<3+>>Al^<3+>, and those among devalent metal cations was Cu^<2+>>Fe^<2+>>Zn^<2+>>Mg^<2+>>Ca^<2+>. The differences in stability constants among quinolones were not as large. Complex structures and metal complex formation equilibria in aqueous solution were proposed. Quinolones were belived to bind metal cations through carboxyl group and carbonyl group of the quinolone ring, and these equilibria show that there are two types of deprotonation reactions from metal complex : the several Fe^<3+> complexes and Al^<3+> complexes liberate protons from coordinated water molecules under acidic to neutral conditions, while the other complexes liberate protons from amine groups under neutral to alkaline conditions. Moreover, quantitative behavior of metal complex in aqueous solution has been demonstrated by simulation for the first time. The simulation especially showed that quinolones interact with Al^<3+> in the stomach, but with Mg^<2+> in the intestines when coadministered with antacid containing Al^<3+> and Mg^<2+>. These results suggest that the complex formation of quinolones with metal cations is an important factor affecting absorption of the former in the gastrointestinal tract.
- 公益社団法人日本薬学会の論文
- 1996-08-15
著者
-
Kawai Yukinori
Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Hakusui H
Drug Metabolism And Analytical Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Kawai Yukinori
Drug Metabolism And Analytical Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Hakusui Hideo
Drug Metabolism & Analytical Chemistry Research Center Developmental Research Laboratories Daiic
-
Matsubayashi Kyuichi
Drug Metabolism And Analytical Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Matsubayashi Kyuichi
Drug Metabolism and Analytical Chemistry Research Laboratory, Daiichi Pharmaceutical Co., Ltd.,
関連論文
- Evaluation of Serum Protein Binding by Using in Vitro Pharmacological Activity for the Effective Pharmacokinetics Profiling in Drug Discovery
- Simple and selective assay of 4-hydroxymephenytoin in human urine using solid-phase extraction and high-performance liquid chromatography with electrochemical detection and its preliminary application to phenotyping test
- Photochemical Behavior of Sitafloxacin, Fluoroquinolone Antibiotic, in an Aqueous Solution
- Chemical Characterization of a Sulfated Polysaccharide-Peptidoglycan Complex from an Arthrobacter sp.
- P7-18 Urinary protein analysis and renal mRNA expression in dogs with renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY P
- Photodecarboxylation of DX-9065a, a New Factor Xa Inhibitor, in Aqueous Solution
- Interaction of Quinolones with Metal Cations in Aqueous Solution
- A Novel Redox Reaction of Ebselen with Alcohol in Basic Solution
- Determination of a new fluoroquinolone antimicrobial agent, (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hemihydrate, DV-7751a, in human serum and urine using so
- A Risk Assessment of Human Ether-a-Go-Go-Related Gene Potassium Channel Inhibition by Using Lipophilicity and Basicity for Drug Discovery